Modulation of the Circadian Rhythm and Oxidative Stress as Molecular Targets to Improve Vascular Dementia: A Pharmacological Perspective

Int J Mol Sci. 2024 Apr 16;25(8):4401. doi: 10.3390/ijms25084401.

Abstract

The circadian rhythms generated by the master biological clock located in the brain's hypothalamus influence central physiological processes. At the molecular level, a core set of clock genes interact to form transcription-translation feedback loops that provide the molecular basis of the circadian rhythm. In animal models of disease, a desynchronization of clock genes in peripheral tissues with the central master clock has been detected. Interestingly, patients with vascular dementia have sleep disorders and irregular sleep patterns. These alterations in circadian rhythms impact hormonal levels, cardiovascular health (including blood pressure regulation and blood vessel function), and the pattern of expression and activity of antioxidant enzymes. Additionally, oxidative stress in vascular dementia can arise from ischemia-reperfusion injury, amyloid-beta production, the abnormal phosphorylation of tau protein, and alterations in neurotransmitters, among others. Several signaling pathways are involved in the pathogenesis of vascular dementia. While the precise mechanisms linking circadian rhythms and vascular dementia are still being studied, there is evidence to suggest that maintaining healthy sleep patterns and supporting proper circadian rhythm function may be important for reducing the risk of vascular dementia. Here, we reviewed the main mechanisms of action of molecular targets related to the circadian cycle and oxidative stress in vascular dementia.

Keywords: circadian rhythm; oxidative stress; pharmacology; vascular dementia.

Publication types

  • Review

MeSH terms

  • Animals
  • Circadian Clocks / genetics
  • Circadian Rhythm*
  • Dementia, Vascular* / drug therapy
  • Dementia, Vascular* / metabolism
  • Dementia, Vascular* / pathology
  • Dementia, Vascular* / physiopathology
  • Humans
  • Molecular Targeted Therapy
  • Oxidative Stress*
  • Signal Transduction / drug effects

Grants and funding

This research received no external funding.